288 related articles for article (PubMed ID: 25496286)
1. Inhibitory effect of D3 dopamine receptor on migration of vascular smooth muscle cells induced by synergistic effect of angiotensin II and aldosterone.
Li Y; Wang N; Chen C; He D; Yang J; Zeng C
Clin Exp Hypertens; 2015; 37(4):288-93. PubMed ID: 25496286
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of D3 dopamine receptors on neuropeptide Y‑induced migration in vascular smooth muscle cells.
Xia XW; Zhou YQ; Luo H; Zeng C
Mol Med Rep; 2017 Oct; 16(4):5606-5610. PubMed ID: 28849020
[TBL] [Abstract][Full Text] [Related]
3. Signaling events mediating the additive effects of oleic acid and angiotensin II on vascular smooth muscle cell migration.
Greene EL; Lu G; Zhang D; Egan BM
Hypertension; 2001 Feb; 37(2):308-12. PubMed ID: 11230290
[TBL] [Abstract][Full Text] [Related]
4. Aldosterone and angiotensin II synergistically stimulate migration in vascular smooth muscle cells through c-Src-regulated redox-sensitive RhoA pathways.
Montezano AC; Callera GE; Yogi A; He Y; Tostes RC; He G; Schiffrin EL; Touyz RM
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1511-8. PubMed ID: 18467645
[TBL] [Abstract][Full Text] [Related]
5. Angiotensin II facilitates neointimal formation by increasing vascular smooth muscle cell migration: Involvement of APE/Ref-1-mediated overexpression of sphingosine-1-phosphate receptor 1.
Lee DY; Won KJ; Lee KP; Jung SH; Baek S; Chung HW; Choi WS; Lee HM; Lee BH; Jeon BH; Kim B
Toxicol Appl Pharmacol; 2018 May; 347():45-53. PubMed ID: 29609002
[TBL] [Abstract][Full Text] [Related]
6. Alpha1beta1 and integrin-linked kinase interact and modulate angiotensin II effects in vascular smooth muscle cells.
Moraes JA; Frony AC; Dias AM; Renovato-Martins M; Rodrigues G; Marcinkiewicz C; Assreuy J; Barja-Fidalgo C
Atherosclerosis; 2015 Dec; 243(2):477-85. PubMed ID: 26520903
[TBL] [Abstract][Full Text] [Related]
7. Activation of the D4 dopamine receptor attenuates proliferation and migration of vascular smooth muscle cells through downregulation of AT1a receptor expression.
Yu C; Chen J; Guan W; Han Y; Wang WE; Wang X; Wang H; Jose PA; Zeng C
Hypertens Res; 2015 Sep; 38(9):588-96. PubMed ID: 25832920
[TBL] [Abstract][Full Text] [Related]
8. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone and angiotensin II synergistically induce mitogenic response in vascular smooth muscle cells.
Min LJ; Mogi M; Li JM; Iwanami J; Iwai M; Horiuchi M
Circ Res; 2005 Sep; 97(5):434-42. PubMed ID: 16081869
[TBL] [Abstract][Full Text] [Related]
10. Thymoquinone Inhibits Angiotensin II-Induced Proliferation and Migration of Vascular Smooth Muscle Cells Through the AMPK/PPARγ/PGC-1α Pathway.
Pei X; Li X; Chen H; Han Y; Fan Y
DNA Cell Biol; 2016 Aug; 35(8):426-33. PubMed ID: 27064837
[TBL] [Abstract][Full Text] [Related]
11. Vascular smooth muscle cell-specific miRNA-214 knockout inhibits angiotensin II-induced hypertension through upregulation of Smad7.
Li Y; Li H; Xing W; Li J; Du R; Cao D; Wang Y; Yang X; Zhong G; Zhao Y; Sun W; Liu C; Gao X; Li Y; Liu Z; Jin X; Zhao D; Tan Y; Wang Y; Liu S; Yuan M; Song J; Chang YZ; Gao F; Ling S; Li Y
FASEB J; 2021 Nov; 35(11):e21947. PubMed ID: 34637552
[TBL] [Abstract][Full Text] [Related]
12. Activation of M3AChR (Type 3 Muscarinic Acetylcholine Receptor) and Nrf2 (Nuclear Factor Erythroid 2-Related Factor 2) Signaling by Choline Alleviates Vascular Smooth Muscle Cell Phenotypic Switching and Vascular Remodeling.
He X; Deng J; Yu XJ; Yang S; Yang Y; Zang WJ
Arterioscler Thromb Vasc Biol; 2020 Nov; 40(11):2649-2664. PubMed ID: 32938216
[TBL] [Abstract][Full Text] [Related]
13. RhoGDI stability is regulated by SUMOylation and ubiquitination via the AT1 receptor and participates in Ang II-induced smooth muscle proliferation and vascular remodeling.
Dai F; Qi Y; Guan W; Meng G; Liu Z; Zhang T; Yao W
Atherosclerosis; 2019 Sep; 288():124-136. PubMed ID: 31362179
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
Jaffe IZ; Mendelsohn ME
Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
[TBL] [Abstract][Full Text] [Related]
15. Exendin-4 Prevents Vascular Smooth Muscle Cell Proliferation and Migration by Angiotensin II via the Inhibition of ERK1/2 and JNK Signaling Pathways.
Nagayama K; Kyotani Y; Zhao J; Ito S; Ozawa K; Bolstad FA; Yoshizumi M
PLoS One; 2015; 10(9):e0137960. PubMed ID: 26379274
[TBL] [Abstract][Full Text] [Related]
16. Egg White-Derived Antihypertensive Peptide IRW (Ile-Arg-Trp) Inhibits Angiotensin II-Stimulated Migration of Vascular Smooth Muscle Cells via Angiotensin Type I Receptor.
Liao W; Fan H; Wu J
J Agric Food Chem; 2018 May; 66(20):5133-5138. PubMed ID: 29714061
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of PTEN expression and activity by angiotensin II induces proliferation and migration of vascular smooth muscle cells.
Dong X; Yu LG; Sun R; Cheng YN; Cao H; Yang KM; Dong YN; Wu Y; Guo XL
J Cell Biochem; 2013 Jan; 114(1):174-82. PubMed ID: 22887358
[TBL] [Abstract][Full Text] [Related]
18. Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro.
Ren L; Liu N; Zhi H; Li Y; Li Y; Tang R; Sheng Z
Cardiovasc Diabetol; 2011 Jan; 10():10. PubMed ID: 21269478
[TBL] [Abstract][Full Text] [Related]
19. RhoA/ROCK Pathway Activation is Regulated by AT1 Receptor and Participates in Smooth Muscle Migration and Dedifferentiation via Promoting Actin Cytoskeleton Polymerization.
Qi Y; Liang X; Dai F; Guan H; Sun J; Yao W
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751352
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-(1-7) counteracts the effects of Ang II on vascular smooth muscle cells, vascular remodeling and hemorrhagic stroke: Role of the NFкB inflammatory pathway.
Bihl JC; Zhang C; Zhao Y; Xiao X; Ma X; Chen Y; Chen S; Zhao B; Chen Y
Vascul Pharmacol; 2015 Oct; 73():115-123. PubMed ID: 26264508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
